sRNAlytics: Pioneering Small RNA Biomarker Discovery

PharmaTechOutlook Top 10 Drug Discovery and Development Solution Providers 2018

We’re at an exciting point in history and just scratching the surface of our understanding of biological information embedded within sequencing data. By unlocking the power of small RNAs and combining them with data science, we are enabling the devolopment of new therapeutics that treat the underlying drivers of disease,” exclaims David Salzman, founder of sRNAlytics.

Small RNAs regulate health and disease within all living things. Their expression patterns are conserved across species and can classify tissue and cell type of origin. They are found
in every type of sample and are extremely stable and easy to extract, making them excellent bioanalytical targets. “The exponential increase in research and publications about small RNA reinforces our excitement, but also highlights significant gaps in today’s approach to harness their power,” Salzman adds…

Read Article